Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017;152(1):157–63. https://www.ncbi.nlm.nih.gov/pubmed/27663604
Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 2018;391(10138):2417–29. https://www.ncbi.nlm.nih.gov/pubmed/29861076
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69(2):406–60. https://www.ncbi.nlm.nih.gov/pubmed/29653741
Quintero E, Gines P, Arroyo V, Rimola A, Bory F, Planas R, et al. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985;1(8429):611–2. https://www.ncbi.nlm.nih.gov/pubmed/2857949
Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013;57(4):1651–3. https://www.ncbi.nlm.nih.gov/pubmed/23463403
